About Climb:
Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. Our product candidates include budoprutug, an anti-CD19 monoclonal antibody that presents us with an exciting opportunity given its broad potential applicability across a number of B-cell mediated diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy and CLYM116, an anti-APRIL monoclonal antibody in development for IgA nephropathy.
At Climb Bio, our team has a knack for seeing what no one else sees—and a drive to achieve results no one expects. We are seeking a self-motivated Clinical Trial Manager to lead end-to-end delivery of clinical trials, with immediate emphasis on owning Phase 1 execution and supporting Phase 2 execution. Reporting to the Director of Clinical Operations, this person will play a critical role in enabling Climb to deliver on its mission.
Key Responsibilities:
Additional Responsibilities:
Qualifications:
Key Competencies:
This role has the option of being remote or hybrid based out of our office in Wellesley, MA.
Base salary offered may vary depending on individual’s skills, experience, and competitive market value.
Salary Range: $132,000-$175,000
Additional total rewards include discretionary annual bonus, comprehensive benefits to include Medical, Dental and Vision, short-term and long-term disability, company paid basic life insurance, 401k company match, generous paid time off and paid holiday, and stock options.
Qualified candidates are encouraged to forward their resumes to [email protected]
Climb is an Equal Opportunity Employer, and we do not discriminate against any employee or applicant for employment because of race, color, sex, age, place of origin, religion, family status, sexual orientation, gender identity, status as a veteran, and disability or any other federal, state, provincial or local protected ground.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
ClimbBio is a clinical-stage biotechnology company focused on developing novel therapies. They are involved in clinical development and strategy, aiming to translate emerging data into actionable insights for program strategy.